However, we have found that the decrease in plasma apelin occurs at an earlier stage of liver disease than for BMP9 and BMP10 suggesting that if BMPR-II signalling is impaired this is not mediated via loss of these receptor ligands. The gene discussed is BMP10; the disease is liver disorder.